GLP-1 price tracker
What the drug makers charge cash-paying patients for every FDA-approved GLP-1, by dose, checked on their own pages each month. October 2026 edition, checked Oct 25, 2026.
- Lowest starting-dose price
- $149
- Lowest maintenance-dose price
- $299
- Products tracked
- 8
- Last checked
- Oct 25, 2026
Price at the dose people stay on
Starting doses are cheap and short. This is the monthly cash price at the labeled maintenance doses, lowest first.
| Product | Dose | Approved for | Per month | Since last month | Condition | Source |
|---|---|---|---|---|---|---|
| Wegovy pillSemaglutide, Novo Nordisk | 25 mg | Weight management, CV risk | $299 | — | NovoCare Wegovy | |
| Ozempic pillSemaglutide, Novo Nordisk | 9 mg | Type 2 diabetes | $299 | — | NovoCare Ozempic | |
| FoundayoOrforglipron, Eli Lilly | 9 mg | Weight management | $299 | — | Foundayo coverage and savings | |
| FoundayoOrforglipron, Eli Lilly | 14.5 or 17.2 mg | Weight management | $299 | — | Refilled within 45 days; otherwise $349 | Foundayo coverage and savings |
| Wegovy penSemaglutide, Novo Nordisk | 2.4 mg | Weight management, CV risk, MASH | $349 | — | NovoCare Wegovy | |
| Wegovy HD penSemaglutide, Novo Nordisk | 7.2 mg | Weight management | $399 | — | NovoCare Wegovy | |
| Zepbound vial or KwikPenTirzepatide, Eli Lilly | 5 mg | Weight management, sleep apnea | $399 | — | LillyDirect Zepbound | |
| Zepbound vial or KwikPenTirzepatide, Eli Lilly | 10 to 15 mg | Weight management, sleep apnea | $449 | — | Refilled within 45 days; otherwise $699 | LillyDirect Zepbound |
| Ozempic penSemaglutide, Novo Nordisk | 2 mg | Type 2 diabetes | $499 | — | NovoCare Ozempic | |
| Mounjaro penTirzepatide, Eli Lilly | All doses | Type 2 diabetes | $499 | — | LillyDirect Mounjaro |
Starting-dose prices
| Product | Dose | Per month | Condition | Source |
|---|---|---|---|---|
| Wegovy pill | 1.5 mg | $149 | NovoCare Wegovy | |
| Ozempic pill | 1.5 mg | $149 | NovoCare Ozempic | |
| Foundayo | 0.8 mg | $149 | Foundayo coverage and savings | |
| Wegovy pen | 0.25 or 0.5 mg | $199 | First 2 fills, new patients, through Dec 31, 2026 | NovoCare Wegovy |
| Ozempic pen | 0.25 or 0.5 mg | $199 | First 2 fills, new patients, through Dec 31, 2026 | NovoCare Ozempic |
| Zepbound vial or KwikPen | 2.5 mg | $299 | LillyDirect Zepbound |
Method
- Prices are the manufacturers' published monthly self-pay prices for a person paying cash with a valid prescription, read from each maker's own page on the date shown. A month is 28 days of injections or 30 tablets.
- Only FDA-approved products are tracked. Compounded versions are excluded: their prices are set by individual pharmacies and programs, and there is no neutral published source to check them against.
- Insurance copay cards are excluded because they apply only to commercially insured people.
- Every snapshot is kept unchanged once published. A wrong figure is fixed in the current month and listed in the corrections log.
Use the data
The CSV has one row per product, dose and month, with the source URL for each price. You may republish it with credit to PeptideSorted and a link to this page (CC BY 4.0). Journalists can ask for earlier notice of a new edition through the contact page.
Archive
- October 2026: 16 prices, checked Oct 25, 2026